Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET PULSE-Apple, GM, Google, Halliburton, Hasbro, Pfizer, Sprint

Mon, 21st Apr 2014 11:43

(For more market insights, including options activity, click on ; for the Day Ahead newsletter http://link.reuters.com/mex49s; for the Morning News Call newsletter, http://link.reuters.com/nex49s)

April 21 -

** HALLIBURTON CO, Thursday close $60.9

The oilfield services company reported a profit for thefirst quarter, compared with a loss a year earlier when itbooked a pre-tax charge of $1 billion related to the Gulf ofMexico spill.

** HASBRO INC, Thursday close $54.61

The toymaker reported a quarterly profit, compared with ayear-ago loss, helped by strong demand for its toys for girls.The company's first-quarter revenue rose 2 percent to $679.5million.

** GENERAL MOTORS CO, Thursday close $33.98

The U.S. car giant plans to invest $12 billion in China from2014 to 2017 and build more plants next year as it competes withaggressive rivals in the world's largest auto market.

** NEWMONT MINING CORP, Thursday close $23.54

The talks between Barrick Gold Corp and NewmontMining over a combination that would create a gold miningbehemoth have hit a snag, but two sources close to the situationsay the companies remain keen on a deal and discussions arelikely to resume.

** PFIZER INC, Thursday close $30.25

The U.S. pharmaceutical giant has approached British rivalAstraZeneca Plc to propose a 60 billion pound ($101billion) takeover, Britain's Sunday Times reported.

** APPLE INC, Thursday close $524.94

** GOOGLE INC, Thursday close $543.34

Apple and Google are wooing game developers to ensure thattop game titles arrive first on devices powered by theirrespective operating system, the Wall Street Journal reported,citing people familiar with the matter.

** KRAFT FOODS GROUP INC, Thursday close $56.91

Kraft Foods is recalling about 96,000 pounds of Oscar MayerClassic Wieners because the packages may instead contain ClassicCheese Dogs made with milk, a known allergen.

** COMCAST CORP, Thursday close $49.1

** CHARTER COMMUNICATIONS INC, Thursday close$56.91

Comcast is in talks with Charter Communications over sellingor spinning off roughly 3 million subscribers worthapproximately $18 billion to $20 billion as part of thedivestitures related to its $45.3 billion takeover of TimeWarner Cable, according to a source familiar with thematter.

** VIMPELCOM LTD, Thursday close $9

Russia's Vimpelcom has resolved a long-running dispute withthe Algerian government by selling it a majority stake in thecountry's biggest telecoms operator for $2.6 billion, while itwill keep control and slash debt.

** AMERICAN TOWER CORP, Thursday close $82.65

Indian conglomerate Reliance Industries Ltd' telecommunications unit, which holds nationwide 4G permits, hasagreed to lease mobile phone masts from infrastructure providerAmerican Tower Corp's local arm, the companies said in astatement on Monday.

** WALT DISNEY CO, Thursday close $79.99

Walt Disney Co's cable networks are expected to record highsingle-digit growth in operating income and domestic affiliaterevenue from fiscal 2014 through 2016, Chief Financial OfficerJay Rasulo told investors on Thursday.

** SPRINT CORP, Thursday close $8.52

** T-MOBILE US INC, Thursday close $30.4

A possible merger between Sprint and T-Mobile could promptU.S. regulators to rewrite rules they are now weighing for a2015 auction of airwaves, according to sources familiar with theproposed regulations.

** LULULEMON ATHLETICA INC, Thursday close $51.71

A U.S. judge has issued final dismissals of lawsuitsaccusing Lululemon and various company officials of defraudingshareholders by concealing defects in yoga pants.

** CHINDEX INTERNATIONAL INC, Thursday close $22.94

Chinese drugmaker Shanghai Fosun Pharmaceutical Group Co Ltd has raised its offer for U.S.-listed ChindexInternational Inc by 15 percent to $223.6 million aftera bidding war for the China-focused hospital chain.

** ATHENAHEALTH, Thursday close $145.58

The healthcare IT services company on Thursday reportedfirst-quarter adjusted earnings and revenue that fell below WallStreet estimates.

Three brokerages, including Oppenheimer, Deutsche Bank andB. Riley cut their price targets on the company' stock, citingweakness in its Epocrates business - a mobile medicalapplication.

** SAREPTA THERAPEUTICS INC, Thursday close $24.4

The company said it would start new trials to revive thechance of approval for its experimental muscle disorder drugafter the U.S. Food and Drug Administration advised the companyto submit new safety and efficacy data.

** SELECT COMFORT CORP, Thursday close $17.75, +3.3 pct after market

The specialty mattress maker on Thursday reportedfirst-quarter sales that beat analysts' estimates, helped by a 2percent rise in comparable sales.

** PEOPLE'S UNITED FINANCIAL INC, Thursday close-100.00

Brokerage Keefe Bruyette & Woods cut the lender's targetprice to $14.50 from $15, citing low profitability until thecompany improves return on assets and efficiency ratio.

** PRIVATEBANCORP INC, Thursday close $29.59

KBW raised its price target on the stock to $34 from $33after the bank reported better-than-expected first quarterresults on Thursday, helped by commercial loan growth.

** LINEAR TECHNOLOGY CORP, Thursday close $46.37

The analog chipmaker said on Thursday it expects revenue togrow 2-6 percent from $348 million in the third quarter, that is$355-$369 million. Analysts on average were expecting revenue of$365 million, according to Thomson Reuters I/B/E/S.

** RADIOSHACK CORP, Thursday close $0

The struggling U.S. electronics chain is mired in talks withits lenders over its plans to close about 1,100 stores,complicating its turnaround efforts, the Wall Street Journalreported, citing sources close to the talks.

RadioShack, which operates about 4,300 stores in the UnitedStates, said in March that the plan needed permission from itslenders, adding that its credit agreements allowed it to closeonly about 200 stores without the approval of lead lenders, theJournal said late on Wednesday. (http://r.reuters.com/vyg68v)

The company reported a wider quarterly loss and a huge dropin sales during the holiday season.

** WEIBO CORP, Thursday close $20.24

The Chinese Twitter-like messaging service company'sU.S.-listed shares were up premarket on Monday after they soared19 percent on their debut on Thursday.

** BIOGEN IDEC INC, Thursday close $290.54

Biogen is pricing its newly approved long-acting hemophiliadrug, Alprolix, to cost U.S. patients, and insurers, about thesame per year as older, less convenient therapies whose pricecan reach about $300,000 annually.

The move could pressure rivals such as Pfizer Inc tolower prices for existing hemophilia treatments, which providepatients with life-saving infusions of a blood clotting agent,according to doctors and industry analysts.

** UNITEDHEALTH GROUP INC, Thursday close $75.78

The largest U.S. health insurer, said it spent more than$100 million to cover a pricey new hepatitis C drug from GileadSciences Inc GILD.O in its first three months on the market, anamount that was "multiple" times what it had expected.

** ABBOTT LABORATORIES, Thursday close $38.93

An Abbott Laboratories spinoff urged a federal appealscourt to revisit a ruling in a case against GlaxoSmithKline Plc, but without disturbing landmark constitutionalprotections for gays and lesbians.

** PLATINUM UNDERWRITERS HOLDINGS LTD, Thursdayclose $62.16, -100.00 pct premarket

Brokerage Keefe Bruyette & Woods raised the reinsuranceprovider's target price to $69 from $67, after the company'searnings for the quarter ended March 31 beat analysts' estimateswith strong underwriting, investing, and capital managementperformance. The company reported earnings per share of $2.27,higher than analysts' average estimate of $1.28, according toThomson Reuters I/B/E/S. [ID: nPn5HRfMd] (Compiled by Rohit T.K. in Bangalore; Editing by Joyjeet Das)

More News
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more
4 Jan 2024 14:01

UK dividends calendar - next 7 days

Friday 5 January 
British Land Co PLCdividend payment date
Hill & Smith PLCdividend payment date
JD Sports Fashion PLCdividend payment date
JPMorgan Global Growth & Income PLCdividend payment date
Liontrust Asset Management PLCdividend payment date
Lok'n Store Group PLCdividend payment date
Real Estate Credit Investments Ltddividend payment date
RS Group PLCdividend payment date
Tate & Lyle PLCdividend payment date
Monday 8 January 
abrdn Equity Income Trust PLCdividend payment date
Intermediate Capital Group PLCdividend payment date
Tuesday 9 January 
no events scheduled 
Wednesday 10 January 
Assura PLCdividend payment date
Bellway PLCdividend payment date
Fidelity Special Values PLCdividend payment date
LXi REIT PLCdividend payment date
Severn Trent PLCdividend payment date
Volex PLCdividend payment date
Vp PLCdividend payment date
Thursday 11 January 
AJ Bell PLCex-dividend payment date
Ashtead Group PLCex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
CMC Markets PLCdividend payment date
dotdigital Group PLCex-dividend payment date
Ecora Resources PLCex-dividend payment date
European Assets Trust PLCex-dividend payment date
Foresight Group Holdings Ltdex-dividend payment date
GSK PLCdividend payment date
ICG-Longbow Senior Secured UK Property Debt Investments Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
Keystone Positive Change Investment Trust PLCex-dividend payment date
LondonMetric Property PLCdividend payment date
Murray International Trust PLCex-dividend payment date
National Grid PLCdividend payment date
Primary Health Properties PLCex-dividend payment date
Sage Group PLCex-dividend payment date
Smiths News PLCex-dividend payment date
SSE PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
TR Property Investment Trust PLCdividend payment date
Walker Crips Group PLCex-dividend payment date
WH Smith PLCex-dividend payment date
Worldwide Healthcare Trust PLCdividend payment date
XPS Pensions Group PLCex-dividend payment date
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.